2027 NCODA Global Oncology & Haematology Congress
March 10, 2027 | 9:00 AM EST
Upcoming Webinar
Evolving Needs and a Treatment Option for R/R Multiple Myeloma
Date: November 18, 2026 | 2:00 PM

Login to Watch this Webinar
To watch the live webinar, login to your account or register to gain access to our exclusive content.
How does ZENBEXUS compare with historical immunomodulatory drugs, and what do the efficacy and safety data show?
Tony Wang, PharmD, JD, walks through its mechanism of action, results for ZENBEXUS with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), and safety findings from EXCALIBER-RRMM and the ZENBEXUS label.
What we’ll cover:
- How ZENBEXUS works compared with historical immunomodulatory drugs
- Efficacy data for the ZDd regimen
- Safety findings from EXCALIBER-RRMM and the ZENBEXUS label
Reach out to Johnny Rivera at [email protected] with any questions or login assistance.
Additional Upcoming Webinars
Send your feedback
Please do not include any personal information or details.
"*" indicates required fields
Was this page
helpful?
Send your feedback
Please do not include any personal information or details.
"*" indicates required fields